These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22519367)

  • 1. Strategies for improving the quantitative bioanalytical performance of LC-MS in pharmacokinetic studies.
    Li L; Tian D; Chen F; Yang J; Yu K; Sun Y
    Curr Drug Metab; 2012 Nov; 13(9):1206-12. PubMed ID: 22519367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of bioanalytical methods for the quantitation of PEGylated human insulin.
    de Dios K; Manibusan A; Marsden R; Pinkstaff J
    J Immunol Methods; 2013 Oct; 396(1-2):1-7. PubMed ID: 23933323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid chromatography-mass spectrometric multiple reaction monitoring-based strategies for expanding targeted profiling towards quantitative metabolomics.
    Guo B; Chen B; Liu A; Zhu W; Yao S
    Curr Drug Metab; 2012 Nov; 13(9):1226-43. PubMed ID: 22519369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery, identification and mitigation of isobaric sulfate metabolite interference to a phosphate prodrug in LC-MS/MS bioanalysis: Critical role of method development in ensuring assay quality.
    Yuan L; Ji QC
    J Pharm Biomed Anal; 2018 Jun; 155():141-147. PubMed ID: 29631074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative and quantitative determination of complicated herbal components by liquid chromatography hybrid ion trap time-of-flight mass spectrometry and a relative exposure approach to herbal pharmacokinetics independent of standards.
    Liang Y; Hao H; Kang A; Xie L; Xie T; Zheng X; Dai C; Wan L; Sheng L; Wang G
    J Chromatogr A; 2010 Jul; 1217(30):4971-9. PubMed ID: 20630198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS.
    Xu RN; Fan L; Rieser MJ; El-Shourbagy TA
    J Pharm Biomed Anal; 2007 Jun; 44(2):342-55. PubMed ID: 17360141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in use of LC/MS/MS for quantitative high-throughput bioanalytical support of drug discovery.
    Ackermann BL; Berna MJ; Murphy AT
    Curr Top Med Chem; 2002 Jan; 2(1):53-66. PubMed ID: 11899065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Large Meets Small': connecting the bioanalytical community around peptide and protein bioanalysis with LC-MS(/MS).
    Timmerman P; Lausecker B; Barosso B; van Amsterdam P; Luedtke S; Dijksman J
    Bioanalysis; 2012 Mar; 4(6):627-31. PubMed ID: 22452251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent development in high-throughput bioanalytical support for in vitro ADMET profiling.
    Shou WZ; Zhang J
    Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):321-36. PubMed ID: 20163321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioanalytical method development and validation: Critical concepts and strategies.
    Moein MM; El Beqqali A; Abdel-Rehim M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1043():3-11. PubMed ID: 27720355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioanalytical LC-MS of therapeutic oligonucleotides.
    van Dongen WD; Niessen WM
    Bioanalysis; 2011 Mar; 3(5):541-64. PubMed ID: 21388267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'LC-electrolyte effects' improve the bioanalytical performance of liquid chromatography/tandem mass spectrometric assays in supporting pharmacokinetic study for drug discovery.
    Wang L; Sun Y; Du F; Niu W; Lu T; Kan J; Xu F; Yuan K; Qin T; Liu C; Li C
    Rapid Commun Mass Spectrom; 2007; 21(16):2573-84. PubMed ID: 17639570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inductively coupled plasma-MS in drug development: bioanalytical aspects and applications.
    van Heuveln F; Meijering H; Wieling J
    Bioanalysis; 2012 Aug; 4(15):1933-65. PubMed ID: 22943623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolite characterization in drug discovery utilizing robotic liquid-handling, quadruple time-of-flight mass spectrometry and in-silico prediction.
    Nassar AE; Adams PE
    Curr Drug Metab; 2003 Aug; 4(4):259-71. PubMed ID: 12871044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LC-FAIMS-MS/MS for quantification of a peptide in plasma and evaluation of FAIMS global selectivity from plasma components.
    Xia YQ; Wu ST; Jemal M
    Anal Chem; 2008 Sep; 80(18):7137-43. PubMed ID: 18652493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LC-MS Development strategies for quantitative bioanalysis.
    Jemal M; Xia YQ
    Curr Drug Metab; 2006 Jun; 7(5):491-502. PubMed ID: 16787158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of Utilizing Natural Isotopologue Transitions in Expanding the Linear Dynamic Range of LC-MS/MS Assay for Small-Molecule Pharmacokinetic Sample Analysis - A Mini-review.
    Bach T; An G
    J Pharm Sci; 2022 May; 111(5):1245-1249. PubMed ID: 34919967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a sensitive LC-MS/MS assay for the simultaneous quantification of allitinib and its two metabolites in human plasma.
    Lin L; Gao Z; Chen X; Zhong D
    J Pharm Biomed Anal; 2013 Dec; 86():49-55. PubMed ID: 23973791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification below the LLOQ in regulated LC-MS/MS assays: a review of bioanalytical considerations and cautions.
    Duggan JX
    Bioanalysis; 2019 Apr; 11(8):797-814. PubMed ID: 30994002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolite identification and pharmacokinetic profiling of PP242, an ATP-competitive inhibitor of mTOR using ultra high-performance liquid chromatography and mass spectrometry.
    Rashid MM; Lee H; Jung BH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():244-251. PubMed ID: 29195143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.